Renvela 800 MG Powder for Oral Suspension

RxCUI: 861377
RxNorm name: Renvela 800 MG Powder for Oral Suspension
Display name: Renvela 800 MG Powder for Oral Suspension
Full name: Renvela 800 MG Powder for Oral Suspension
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:25

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Renvela	SEVELAMER CARBONATE	Genzyme Corporation	e6328460-a57b-450b-a48c-6dcd4b476360	2025-11-25	Warnings, Adverse reactions	Exact identifier rxcui: 861377

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
e6328460-a57b-450b-a48c-6dcd4b476360	Renvela 0.8 GM Powder for Oral Suspension [PSN] · sevelamer carbonate 800 MG Powder for Oral Suspension [Renvela] [SBD] · Renvela 0.8 GM Powder for Oral Suspension [SY] · Renvela 800 MG Powder for Oral Suspension [SY]	4	47	These highlights do not include all the information needed to use RENVELA safely and effectively. See full prescribing information for RENVELA. RENVELA (sevelamer carbonate) tablets, for oral use RENVELA (sevelamer carbonate) powder, for oral suspension Initial U.S. Approval: 2000	20251125